Gan & Lee Pharmaceuticals. (SHA:603087)

China · Delayed Price · Currency is CNY

58.96

-0.15 (-0.25%)

Mar 26, 2026, 11:29 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Development, Production and Sales of Insulin and Related Products	3.05B	2.61B	1.71B	3.61B	3.36B
Development, Production and Sales of Insulin and Related Products Growth	16.77%	52.31%	-52.60%	7.44%	16.12%
Total	3.05B	2.61B	1.71B	3.61B	3.36B
Total Growth	16.77%	52.31%	-52.60%	7.44%	16.12%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	2.52B	-	-	-	-
International	527.75M	-	-	-	-
Total	3.05B	-	-	-	-

Source: S&P Global Market Intelligence.